Myra Kleinpeter is a Nephrology physician affiliated with Tulane University. OpenAlex indexes 47 publications with 962 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1415 Tulane Ave
New Orleans, LA 701122600
Telephone
504-988-2300Registry record last updated 18 Mar 2015.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Vantive US Healthcare LLCProgram year20252 payments
- Mallinckrodt Hospital Products Inc.Program year20251 payment
- GENZYME CORPORATIONProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
55.2%Beta blocker13.7%Carvedilol39%Metoprolol Succinate29%Labetalol Hcl18%Metoprolol Tartrate14%Part D<11 patientsCalcium channel blocker13%Amlodipine Besylate77%Nifedipine Er23%Part D<11 patients+ 9 more classes in this area
Other
20.2%Phosphate Binder14.9%Sevelamer Carbonate100%Part D≥34 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia5.4%Velphoro100%Part D≥11 patientsMetabolism & gastrointestinal
14.5%H2 blocker4.2%Famotidine100%Part D≥11 patientsProton pump inhibitor2.4%Pantoprazole Sodium100%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Risk Factors for Total Stroke in Patients with CKD: The Chronic Renal Insufficiency Cohort Study
Journal of the American Society of Nephrology
2024 - Evaluation of the Effect of Racial Differences on Longitudinal Trajectories of Kidney Function in People with HIV (PWH) on Tenofovir Alafenamide (TAF)-Based Antiretroviral Treatment (ART) Regimens
Journal of the American Society of Nephrology
2024 - Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop
American Journal of Kidney Diseases
2020 - Combination Treatment with Sodium Nitrite and Isoquercetin on Endothelial Dysfunction among Patients with CKD
Clinical Journal of the American Society of Nephrology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Erik Castle, MD
Tulane University
John Schieffelin, MD
Tulane University
Thierry Lejemtel, MD
Tulane University
Robert Hendel, MD
Tulane University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”